Cyclopharm

Cyclopharm Operating Expenses

The Total Operating Expenses of Cyclopharm (CYC.AX) as of Nov 12, 2026 is 24.23 M AUD. In the previous year, Total Operating Expenses was 21.84 M AUD — a change of 10.93% (higher).

Operating Expenses

24.23 MAUD

YoY

10.93%

Last updated:

Total Operating Expenses of Cyclopharm is 2025 24.23 M AUD. Total Operating Expenses of Cyclopharm was 2024 21.84 M AUD. It decreases by 10.93% higher compared to the previous year.

The Cyclopharm Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
9.10 M AUD
Jan 1, 2019
10.57 M AUD
Jan 1, 2020
13.01 M AUD
Jan 1, 2021
12.45 M AUD
Jan 1, 2022
14.40 M AUD
Jan 1, 2023
17.69 M AUD
Jan 1, 2024
21.84 M AUD
Jan 1, 2025
24.23 M AUD
The Cyclopharm Operating Expenses history
YEAROperating ExpensesYoY
24.23 MAUD+10.93%
21.84 MAUD+23.47%
17.69 MAUD+22.80%
14.40 MAUD+15.67%
12.45 MAUD-4.26%
13.01 MAUD+23.07%
10.57 MAUD+16.12%
9.10 MAUD+10.29%
8.25 MAUD+31.91%
6.26 MAUD+32.54%
4.72 MAUD+10.10%
4.29 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cyclopharm Stock analysis

What does Cyclopharm do? Cyclopharm Ltd is an Australian company that was founded in 1986 and has since been developing innovative medical solutions. The company operates in the field of nuclear medicine and focuses on providing diagnostic and therapeutic products and services. The history of Cyclopharm Ltd began with the development of the Technetium-99m generator, an instrument for generating radioisotopes that can be used in medical imaging. Since then, the company has expanded its offerings and now offers a wide range of products and services. Cyclopharm Ltd's business model is based on research and development of new solutions based on the needs of the medical community and patients. The company works closely with doctors, scientists, and other experts to ensure that its products and services meet the highest standards. Cyclopharm Ltd is divided into various divisions to coordinate and optimize its activities. These include diagnostics, therapy, research and development, as well as sales and marketing. Each division works closely with the others to ensure that the company achieves its goals and provides optimal customer care. Some of Cyclopharm Ltd's most well-known products include the Technetium-99m generator and the radiopharmaceutical Technegas. Technegas is a gas used for lung imaging and plays an important role in diagnosing lung problems. The radiopharmaceutical is produced using the Technetium-99m generator and is an important addition to medical imaging. In addition, Cyclopharm Ltd also develops therapeutic solutions that can be used to treat cancer and other diseases. These include radiopharmaceuticals used in radiation therapy, as well as other solutions tailored to the individual needs of patients. Cyclopharm Ltd is also actively working on improving and expanding its products and services. The company invests in research and development to develop innovative solutions that can improve medical imaging and therapy. Additionally, the company works closely with its customers to better understand their needs and offer them tailored solutions. Overall, Cyclopharm Ltd is an innovative and goal-oriented company that focuses on providing diagnostic and therapeutic solutions in the field of nuclear medicine. The company has a long history of leadership in this field and will continue to be at the forefront of developing solutions that improve the lives of patients and medical professionals. Cyclopharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cyclopharm stock

Total Operating Expenses of Cyclopharm is 24.23 M AUD in 2025.

Total Operating Expenses of Cyclopharm changed from 21.84 M AUD to 24.23 M AUD, representing a 10.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Cyclopharm since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Cyclopharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Cyclopharm

All Key Metrics — Cyclopharm